BioMarin Pharmaceutical (BMRN) Beats Q1 Earnings and Revenue Estimates

BioMarin Pharmaceutical (BMRN) came out with quarterly earnings of $1.13 per share, beating the Zacks Consensus Estimate of$ 0.94 per share. This compares to earnings of $0.71 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 20.21%. A quarter ago, it was expected that this rare disease biopharmaceutical would post earnings of$ 0.73 per share when it actually produced earnings of $0.92, delivering a surprise of 26.03%.Over the l ...